Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Wwp2em1/Cya
Common Name:
Wwp2-KO
Product ID:
S-KO-11981
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Wwp2-KO
Strain ID
KOCMP-66894-Wwp2-B6J-VA
Gene Name
Wwp2
Product ID
S-KO-11981
Gene Alias
1300010O06Rik; AIP2
Background
C57BL/6JCya
NCBI ID
66894
Modification
Conventional knockout
Chromosome
8
Phenotype
MGI:1914144
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Wwp2em1/Cya mice (Catalog S-KO-11981) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000166615
NCBI RefSeq
NM_025830
Target Region
Exon 5~6
Size of Effective Region
~2.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
WWP2, an E3 ubiquitin ligase, plays a crucial role in regulating numerous cellular biological activities. It exerts its function through the ubiquitination and degradation of its substrates, participating in various pathways such as the PTEN/Akt signaling pathway. This gene is of great biological importance as it is involved in processes like DNA repair, gene expression, signal transduction, and cell-fate decisions, and is thus linked to normal physiology and various diseases [1,8].

In different disease models, WWP2 shows distinct functions. In cardiac remodeling, myocardial-specific knockout of WWP2 decreased PARP1 ubiquitination, aggravating isoproterenol-induced myocardial hypertrophy, heart failure, and fibrosis, suggesting its role in regulating cardiac remodeling through the WWP2-PARP1 pathway [2]. In renal fibrosis, WWP2 deficiency promoted myofibroblast proliferation while halting profibrotic activation, reducing the severity of renal fibrosis in vivo, and it regulated the metabolic reprogramming of profibrotic myofibroblasts via the WWP2-PGC-1α axis [3]. In heart fibrosis, myeloid-specific deletion of WWP2 reduced cardiac fibrosis in hypertension-induced non-ischemic cardiomyopathy by affecting pro-fibrogenic Ly6chigh monocytes [4]. In Type 2 diabetes mellitus-induced vascular endothelial injury, endothelial-specific knockout of Wwp2 in mice aggravated the injury, indicating that down-regulation of WWP2 exacerbates this condition [5]. In breast cancer, lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1 [6]. In sepsis-induced cardiac injury, cardiac-specific overexpression of WWP2 protected the heart from injury, while knockdown or knockout exacerbated the process, with WWP2 acting by suppressing cardiomyocyte ferroptosis [7].

In conclusion, WWP2 is a key regulator in multiple biological processes and diseases. Gene knockout and conditional knockout mouse models have been instrumental in revealing its functions in areas such as cardiac remodeling, renal fibrosis, heart fibrosis, vascular endothelial injury, breast cancer metastasis, and sepsis-induced cardiac injury. Understanding WWP2 provides insights into disease mechanisms and potential therapeutic targets.

References:

1. Zhang, Rui, Zhang, Jianwu, Luo, Wei, Luo, Zhuang, Shi, Shaoqing. 2018. WWP2 Is One Promising Novel Oncogene. In Pathology oncology research : POR, 25, 443-446. doi:10.1007/s12253-018-0506-5. https://pubmed.ncbi.nlm.nih.gov/30415470/

2. Zhang, Naijin, Zhang, Ying, Qian, Hao, Cao, Liu, Sun, Yingxian. 2020. Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling. In Cell death and differentiation, 27, 2605-2619. doi:10.1038/s41418-020-0523-2. https://pubmed.ncbi.nlm.nih.gov/32139900/

3. Chen, Huimei, You, Ran, Guo, Jing, Zhang, Aihua, Petretto, Enrico. 2024. WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts. In Journal of the American Society of Nephrology : JASN, 35, 696-718. doi:10.1681/ASN.0000000000000328. https://pubmed.ncbi.nlm.nih.gov/38502123/

4. Chen, Huimei, Chew, Gabriel, Devapragash, Nithya, Behmoaras, Jacques, Petretto, Enrico. 2022. The E3 ubiquitin ligase WWP2 regulates pro-fibrogenic monocyte infiltration and activity in heart fibrosis. In Nature communications, 13, 7375. doi:10.1038/s41467-022-34971-6. https://pubmed.ncbi.nlm.nih.gov/36450710/

5. You, Shilong, Xu, Jiaqi, Yin, Zeyu, Sun, Yingxian, Zhang, Naijin. 2023. Down-regulation of WWP2 aggravates Type 2 diabetes mellitus-induced vascular endothelial injury through modulating ubiquitination and degradation of DDX3X. In Cardiovascular diabetology, 22, 107. doi:10.1186/s12933-023-01818-3. https://pubmed.ncbi.nlm.nih.gov/37149668/

6. Zhang, Zhen, Lu, Yun-Xin, Liu, Fangzhou, Li, Xu, Lin, Aifu. 2023. lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2206694120. doi:10.1073/pnas.2206694120. https://pubmed.ncbi.nlm.nih.gov/36795754/

7. Li, Zhi, Wu, Boquan, Chen, Jie, Zhang, Xingang, Sun, Guozhe. 2024. WWP2 protects against sepsis-induced cardiac injury through inhibiting cardiomyocyte ferroptosis. In Journal of translational internal medicine, 12, 35-50. doi:10.2478/jtim-2024-0004. https://pubmed.ncbi.nlm.nih.gov/38591063/

8. You, Shilong, Xu, Jiaqi, Guo, Yushan, Sun, Guozhe, Sun, Yingxian. 2024. E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases. In Molecular aspects of medicine, 96, 101257. doi:10.1016/j.mam.2024.101257. https://pubmed.ncbi.nlm.nih.gov/38430667/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest